Neutrophil gelatinase associated lipocalin: a new marker for early diagnosis of acute kidney injury in ICU

NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN HEPATIC PATIENTS

Predictability of at-admission Plasma Neutrophil Gelatinase– associated Lipocalin (NGAL) Level for Acute Kidney Injury in Patients admitted to Surgical Intensive Care Unit

Plasma and Urinary NGAL-2 as Early Biomarkers for Diagnosis of Acute Kidney Injury in Pediatric Post-Operative Cardiac Patients

The value of urine neutrophil gelatinase-associated lipocalin in the prediction of septic acute kidney injury, dialysis need, and mortality in a cohort of Eegyptian sepsis patient

Serum neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in patients with coronary artery disease

Urinary Neutrophil Gelatinase Associated lipocalin (NGAL) as A Biomarker of Acute Kidney Injury in Patients with Liver Cirrhosis

NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN LEVEL IN THE BLOOD AS A PREDICTOR OF EARLY AND LATE ONSET NEONATAL SEPSIS

Urinary neutrophil gelatinase associated lipocalin (NGAL) as an early marker of acute kidney injury in septic patients

Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin are early predictors for acute kidney injury among patients admitted to the surgical ICU